3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
7
Specimen Handling
5
fludarabine
4
Standard of Care
4
trametinib
3
Practice Guidelines as Topic
3
Mycophenolic Acid
3
Magnetic Resonance Spectroscopy
3
GSK2636771
3
Biopsy
3
venetoclax
2
talquetamab
2
osimertinib
2
dabrafenib
2
binimetinib
2
X-Rays
2
Whole-Body Irradiation
2
Thiotepa
2
Tacrolimus
2
Surveys and Questionnaires
2
Patient Navigation
2
Nivolumab
2
Methods
2
Mesna
2
Melphalan
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Crizotinib
2
Ado-Trastuzumab Emtansine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.